Phase I/II trial of WT1 Cancer Vaccine in patients Glioblastoma multiforme
Phase of Trial: Phase I/II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Galinpepimut S (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 20 Oct 2016 Trial phase is assumed according to Sellas Life Sciences pipeline.
- 20 Oct 2016 According to Sellas Life Sciences pipeline this trial is phase I/II and company is planning to initiate this trial in Jan 2017.
- 15 Jan 2016 New trial record